SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    David J. Mener, Sandra Y. Lin, Improvement and prevention of asthma with concomitant treatment of allergic rhinitis and allergen-specific therapy, International Forum of Allergy & Rhinology, 2015, 5, S1
  2. 2
    Cemal Cingi, Nuray Bayar Muluk, Deniz Hanci, Seckin Ulusoy, Fezan Sahin, Updating the role played by immunotherapy for allergic rhinitis: meta-analysis, International Forum of Allergy & Rhinology, 2015, 5, 2
  3. 3
    Yoshitaka Okamoto, Nobuo Ohta, Mitsuhiro Okano, Atsushi Kamijo, Minoru Gotoh, Motohiko Suzuki, Sachio Takeno, Tetsuya Terada, Toyoyuki Hanazawa, Shigetoshi Horiguchi, Kohei Honda, Shoji Matsune, Takechiyo Yamada, Atsushi Yuta, Takeo Nakayama, Shigeharu Fujieda, Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan, Auris Nasus Larynx, 2014, 41, 1, 1

    CrossRef

  4. 4
    Elina Toskala, Immunology, International Forum of Allergy & Rhinology, 2014, 4, S2
  5. 5
    Rachel Georgopoulos, John H. Krouse, Elina Toskala, Why Otolaryngologists and Asthma Are a Good Match, Otolaryngologic Clinics of North America, 2014, 47, 1, 1

    CrossRef

  6. 6
    Cheryl S. Hankin, Linda Cox, Amy Bronstone, Zhaohui Wang, Allergy immunotherapy: Reduced health care costs in adults and children with allergic rhinitis, Journal of Allergy and Clinical Immunology, 2013, 131, 4, 1084

    CrossRef

  7. 7
    Mohamed H Shamji, Christian Ljørring, Peter A Würtzen, Predictive biomarkers of clinical efficacy of allergen-specific immunotherapy: how to proceed, Immunotherapy, 2013, 5, 3, 203

    CrossRef

  8. 8
    Gyu-Young Hur, Treatment of Allergic Rhinitis, Korean Journal of Medicine, 2013, 85, 5, 463

    CrossRef

  9. 9
    Lars Jacobsen, Ulrich Wahn, M Beatrice Bilo, Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy, Clinical and Translational Allergy, 2012, 2, 1, 8

    CrossRef

  10. 10
    Ayfer Yukselen, Seval Güneser Kendirli, Mustafa Yilmaz, Derya Ufuk Altintas, Gulbin Bingol Karakoc, Effect of One-Year Subcutaneous and Sublingual Immunotherapy on Clinical and Laboratory Parameters in Children with Rhinitis and Asthma: A Randomized, Placebo-Controlled, Double-Blind, Double-Dummy Study, International Archives of Allergy and Immunology, 2012, 157, 3, 288

    CrossRef

  11. 11
    Tania Mucci, Satish Govindaraj, Jody Tversky, Allergic Rhinitis, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 5
  12. 12
    Sunit P. Jariwala, Satya Kurada, Heather Moday, Andy Thanjan, Laurel Bastone, Moisey Khananashvili, Jason Fodeman, Golda Hudes, David Rosenstreich, Association between Tree Pollen Counts and Asthma ED Visits in a High-Density Urban Center, Journal of Asthma, 2011, 48, 5, 442

    CrossRef

  13. 13
    Louis-Philippe Boulet, Marie-Ève Boulay, Asthma-related comorbidities, Expert Review of Respiratory Medicine, 2011, 5, 3, 377

    CrossRef

  14. You have free access to this content14
    M. T. Krishna, A. P. Huissoon, Clinical immunology review series: an approach to desensitization, Clinical & Experimental Immunology, 2011, 163, 2
  15. 15
    Yekaterina A. Koshkareva, John H. Krouse, Immunotherapy – Traditional, Otolaryngologic Clinics of North America, 2011, 44, 3, 741

    CrossRef

  16. 16
    Linda Cox, Dana Wallace, Specific Allergy Immunotherapy for Allergic Rhinitis: Subcutaneous and Sublingual, Immunology and Allergy Clinics of North America, 2011, 31, 3, 561

    CrossRef

  17. 17
    Cheryl S. Hankin, Linda Cox, David Lang, Amy Bronstone, Paul Fass, Bryan Leatherman, Zhaohui Wang, Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study, Annals of Allergy, Asthma & Immunology, 2010, 104, 1, 79

    CrossRef

  18. 18
    A. Magnan, F. Wessel, J.-P. Meunier, A. Chartier, Grazax® – Immunothérapie spécifique sous forme de lyophilisat oral d’un extrait de fléole dans la prise en charge de l’allergie aux pollens de graminées : étude observationnelle en médecine ambulatoire, Revue Française d'Allergologie, 2010, 50, 1, 7

    CrossRef

  19. 19
    O. Pfaar, D. S. Robinson, A. Sager, R. Emuzyte, Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis, Allergy, 2010, 65, 12
  20. 20
    Stephen R. Durham, Waltraud Emminger, Alexander Kapp, Giselda Colombo, Jan G.R. de Monchy, Sabina Rak, Glenis K. Scadding, Jens S. Andersen, Bente Riis, Ronald Dahl, Long-term clinical efficacy in grass pollen–induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet, Journal of Allergy and Clinical Immunology, 2010, 125, 1, 131

    CrossRef

  21. 21
    F. Rancé, A. Deschildre, E. Bidat, J. Just, L. Couderc, S. Wanin, L. Weiss, Prévention secondaire et tertiaire de l’asthme allergique de l’enfant, Revue des Maladies Respiratoires, 2010, 27, 10, 1221

    CrossRef

  22. 22
    François Spertini, Christophe Reymond, Annette Leimgruber, Allergen-specific immunotherapy of allergy and asthma: current and future trends, Expert Review of Respiratory Medicine, 2009, 3, 1, 37

    CrossRef

  23. 23
    Ad Jansen, Kristian Funding Andersen, Harald Brüning, Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets (GRAZAX®) in a randomized, open-label, controlled study: An a priori subgroup analysis, Clinical Therapeutics, 2009, 31, 2, 321

    CrossRef

  24. 24
    Robert A. Nathan, Management of Patients with Allergic Rhinitis and Asthma: Literature Review, Southern Medical Journal, 2009, 102, 9, 935

    CrossRef

  25. 25
    F. Rancé, A. Deschildre, É. Bidat, J. Just, L. Couderc, S. Wanin, L. Weiss, Prévention secondaire et tertiaire de l’asthme allergique de l’enfant, Revue Française d'Allergologie, 2009, 49, 8, 585

    CrossRef

  26. 26
    Cheryl S. Hankin, Linda Cox, David Lang, Arthur Levin, Gary Gross, Gene Eavy, Eli Meltzer, Doug Burgoyne, Amy Bronstone, Zhaohui Wang, Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: Patterns of care, resource use, and costs, Journal of Allergy and Clinical Immunology, 2008, 121, 1, 227

    CrossRef

  27. 27
    Matthew W. Ryan, Asthma and Rhinitis: Comorbidities, Otolaryngologic Clinics of North America, 2008, 41, 2, 283

    CrossRef

  28. 28
    Gabrielle Pauli, Tina H. Larsen, Sabina Rak, Friedrich Horak, Elide Pastorello, Rudolph Valenta, Ashok Purohit, Monica Arvidsson, Alexander Kavina, Jan W. Schroeder, Nadine Mothes, Susanne Spitzauer, Armelle Montagut, Sylvie Galvain, Michel Melac, Claude André, Lars K. Poulsen, Hans-Jorgen Malling, Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis, Journal of Allergy and Clinical Immunology, 2008, 122, 5, 951

    CrossRef

  29. 29
    M. G. Stewart, Identification and management of undiagnosed and undertreated allergic rhinitis in adults and children, Clinical & Experimental Allergy, 2008, 38, 5
  30. 30
    Susanne Halken, Susanne Lau, Erkka Valovirta, New visions in specific immunotherapy in children: an iPAC summary and future trends, Pediatric Allergy and Immunology, 2008, 19,
  31. 31
    Robert E. Esch, Robert K. Bush, David Peden, Richard F. Lockey, Sublingual-oral administration of standardized allergenic extracts: phase 1 safety and dosing results, Annals of Allergy, Asthma & Immunology, 2008, 100, 5, 475

    CrossRef

  32. 32
    Linda Cox, James T. Li, Harold Nelson, Richard Lockey, Allergen immunotherapy: A practice parameter second update, Journal of Allergy and Clinical Immunology, 2007, 120, 3, S25

    CrossRef

  33. 33
    Linda Cox, John R. Cohn, Duration of allergen immunotherapy in respiratory allergy: when is enough, enough?, Annals of Allergy, Asthma & Immunology, 2007, 98, 5, 416

    CrossRef

  34. 34
    Lars Jacobsen, Erkka Valovirta, How strong is the evidence that immunotherapy in children prevents the progression of allergy and asthma?, Current Opinion in Allergy and Clinical Immunology, 2007, 7, 6, 556

    CrossRef

  35. 35
    Sabina Rak, William H. Yang, Martin R. Pedersen, Stephen R. Durham, Once-daily sublingual allergen-specific immunotherapy improves quality of life in patients with grass pollen-induced allergic rhinoconjunctivitis: A double-blind, randomised study, Quality of Life Research, 2007, 16, 2, 191

    CrossRef

  36. 36
    C. Neukirch, Allergies respiratoires de l'adulte : diagnostic et prise en charge thérapeutique, EMC - Traité de médecine AKOS, 2006, 1, 1, 1

    CrossRef

  37. 37
    B. Niggemann, L. Jacobsen, S. Dreborg, H. A. Ferdousi, S. Halken, A. Høst, A. Koivikko, D. Koller, L. A. Norberg, R. Urbanek, E. Valovirta, U. Wahn, C. Möller, Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children, Allergy, 2006, 61, 7
  38. 38
    A. M. Ejrnaes, M. Svenson, G. Lund, J. N. Larsen, H. Jacobi, Inhibition of rBet v 1-induced basophil histamine release with specific immunotherapy -induced serum immunoglobulin G: no evidence that FcγRIIB signalling is important, Clinical & Experimental Allergy, 2006, 36, 3
  39. 39
    David B.K. Golden, Insect sting allergy and venom immunotherapy, Annals of Allergy, Asthma & Immunology, 2006, 96, 2, S16

    CrossRef

  40. 40
    C. Gallen, Specific immunotherapy and atopy, Revue Française d'Allergologie et d'Immunologie Clinique, 2006, 46, S35

    CrossRef

  41. 41
    Giovanni B Pajno, Status of immunotherapy: is the time ripe for the secondary prevention of asthma and allergy?, Expert Review of Clinical Immunology, 2006, 2, 4, 485

    CrossRef

  42. 42
    P. A. Eng, M. Borer-Reinhold, I. A. F. M. Heijnen, H. P. E. Gnehm, Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood, Allergy, 2006, 61, 2
  43. 43
    Riccardo Asero, Bernhard Weber, Gianni Mistrello, Stefano Amato, Enzo Madonini, Oliver Cromwell, Giant ragweed specific immunotherapy is not effective in a proportion of patients sensitized to short ragweed: Analysis of the allergenic differences between short and giant ragweed, Journal of Allergy and Clinical Immunology, 2005, 116, 5, 1036

    CrossRef

  44. 44
    Riccardo Asero, Lack of de novo Sensitization to Tropomyosin in a Group of Mite-Allergic Patients Treated by House Dust Mite-Specific Immunotherapy, International Archives of Allergy and Immunology, 2005, 137, 1, 62

    CrossRef

  45. 45
    Wiqar A. Shaikh, Long-term Efficacy of House Dust Mite Immunotherapy in Bronchial Asthma: A 15-year Follow-up Study, Allergology International, 2005, 54, 3, 443

    CrossRef

  46. 46
    Moisés Calderón-Zapata, Stephen Durham, Asthma Prevention, 2005,

    CrossRef

  47. 47
    R. J. J. Van Neerven, M. Arvidsson, H. Ipsen, S. H. Sparholt, S. Rak, P.A. Würtzen, A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation, Clinical & Experimental Allergy, 2004, 34, 3
  48. 48
    C. Neukirch, Alergias respiratorias en el adulto: diagnóstico y tratamiento, EMC - Tratado de Medicina, 2004, 8, 4, 1

    CrossRef

  49. 49
    C Neukirch, Allergies respiratoires de l'adulte : diagnostic et prise en charge thérapeutique, EMC - Médecine, 2004, 1, 4, 295

    CrossRef

  50. 50
    M. S. Khinchi, L. K. Poulsen, F. Carat, C. André, A. B. Hansen, H.-J. Malling, Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study, Allergy, 2004, 59, 1
  51. 51
    R. Polosa, F. Li Gotti, G. Mangano, G. Paolino, C. Mastruzzo, C. Vancheri, N. Lisitano, N. Crimi, Effect of immunotherapy on asthma progression, BHR and sputum eosinophils in allergic rhinitis, Allergy, 2004, 59, 11
  52. 52
    Riccardo Asero, Efficacy of Injection Immunotherapy with Ragweed and Birch Pollen in Elderly Patients, International Archives of Allergy and Immunology, 2004, 135, 4, 332

    CrossRef

  53. 53
    M.ªF. Martín Muñoz, Eficacia de la inmunoterapia en el tratamiento del asma, Allergologia et Immunopathologia, 2004, 32, 3, 133

    CrossRef

  54. 54
    James T. Li, Richard F. Lockey, I. Leonard Bernstein, Jay M. Portnoy, Richard A. Nicklas, Allergen immunotherapy: a practice parameter, Annals of Allergy, Asthma & Immunology, 2003, 90, 1, 1

    CrossRef

  55. 55
    A. Amoresano, P. Pucci, G. Duro, P. Colombo, M. A. Costa, V. Izzo, D. Lamba, D. Geraci, Assignment of Disulphide Bridges in Par j 2.0101, a Major Allergen of Parietaria judaica Pollen, Biological Chemistry, 2003, 384, 8

    CrossRef

  56. 56
    R. Asero, How long does the effect of birch pollen injection SIT on apple allergy last?, Allergy, 2003, 58, 5
  57. 57
    Robert Movérare, Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies, Expert Review of Vaccines, 2003, 2, 1, 85

    CrossRef

  58. 58
    Arthur Helbling, Andrea Reimers, Immunotherapy in fungal allergy, Current Allergy and Asthma Reports, 2003, 3, 5, 447

    CrossRef

  59. 59
    H Malandain, Quelle valeur clinique accorder aux résultats chiffrés des dosages d'IgE spécifiques ?, Immuno-analyse & Biologie Spécialisée, 2003, 18, 3, 144

    CrossRef

  60. 60
    Monica B. Arvidsson, Olle Löwhagen, Sabina Rak, Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy, Journal of Allergy and Clinical Immunology, 2002, 109, 5, 777

    CrossRef

  61. 61
    P. A. Eng, M. Reinhold, HP. E. Gnehm, Long-term efficacy of preseasonal grass pollen immunotherapy in children, Allergy, 2002, 57, 4
  62. 62
    Christian Möller, Sten Dreborg, Hosne A. Ferdousi, Susanne Halken, Arne Høst, Lars Jacobsen, Antti Koivikko, Dieter Y. Koller, Bodo Niggemann, Lene A. Norberg, Radvan Urbanek, Erkka Valovirta, Ulrich Wahn, Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study), Journal of Allergy and Clinical Immunology, 2002, 109, 2, 251

    CrossRef

  63. 63
    H. Malandain, Quelle valeur clinique accorder aux résultats chiffrés des dosages d'IgE spécifiques ?, Revue Française d'Allergologie et d'Immunologie Clinique, 2002, 42, 8, 798

    CrossRef

  64. 64
    U. Bødtger, L. K. Poulsen, H. H. Jacobi, H.-J. Malling, The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study, Allergy, 2002, 57, 4
  65. 65
    Fulvio Mastrandrea, Immunotherapy in atopic dermatitis, Expert Opinion on Investigational Drugs, 2001, 10, 1, 49

    CrossRef

  66. 66
    Robert Movérare, Erkki Vesterinen, Tuula Metso, Ritva Sorva, Lena Elfman, Tari Haahtela, Pollen-specific rush immunotherapy: clinical efficacy and effects on antibody concentrations, Annals of Allergy, Asthma & Immunology, 2001, 86, 3, 337

    CrossRef

  67. 67
    F. Purello-D'Ambrosio, S. Gangemi, R. A. Merendino, S. Isola, P. Puccinelli, S. Parmiani, L. Ricciardi, Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study, Clinical & Experimental Allergy, 2001, 31, 8
  68. 68
    Lars Jacobsen, Preventive aspects of immunotherapy: prevention for children at risk of developing asthma, Annals of Allergy, Asthma & Immunology, 2001, 87, 1, 43

    CrossRef

  69. 69
    Robert Movérare, Lena Elfman, Eythor Björnsson, Gunnemar Stålenheim, Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy, Immunology Letters, 2000, 73, 1, 51

    CrossRef

  70. 70
    James T. Li, IMMUNOTHERAPY FOR ALLERGIC RHINITIS, Immunology and Allergy Clinics of North America, 2000, 20, 2, 383

    CrossRef

  71. 71
    E. Alvarez-Cuesta, E. Gonzélez-Mancebo, Immunotherapy in bronchial asthma, Current Opinion in Pulmonary Medicine, 2000, 6, 1, 50

    CrossRef

  72. 72
    M. Cools, H.P. Van Bever, J.J. Weyler, W.J. Stevens, Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen, Allergy, 2000, 55, 1
  73. 73
    Jørgen N. Larsen, Henning Løwenstein, MANUFACTURING AND STANDARDIZING ALLERGEN VACCINES, Immunology and Allergy Clinics of North America, 2000, 20, 3, 609

    CrossRef

  74. 74
    E. Valovirta, Can the natural course of allergy and asthma be changed by allergen vaccinations?, Allergy, 1999, 54,
  75. 75
    Stephen R. Durham, Samantha M. Walker, Eva-Maria Varga, Mikila R. Jacobson, Fiona O'Brien, Wendy Noble, Stephen J. Till, Qutayba A. Hamid, Kayhan T. Nouri-Aria, Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy, New England Journal of Medicine, 1999, 341, 7, 468

    CrossRef

  76. 76
    R Ariano, AM Kroon, G Augeri, GW Canonica and , G Passalacqua, Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial , Allergy, 1999, 54, 4
  77. 77
    Ana Fernandes, Tópicos para melhorar o controlo da asma, Revista Portuguesa de Pneumologia, 1999, 5, 1, 50

    CrossRef

  78. 78
    Allergen immunotherapy: therapeutic vaccines for allergic diseases, Allergy, 1998, 53,
  79. 79
    Michael J Abramson, Robert M Puy, John M Weiner, Allergen immunotherapy for asthma, The Cochrane Library,
  80. 80
    Michael J Abramson, Robert M Puy, John M Weiner, Injection allergen immunotherapy for asthma, The Cochrane Library,